Latest News for: cimzia

Edit

Xbrane has entered into an agreement to sell XB003 (Cimzia biosimilar candidate) and parts of its organization to Alvotech for a total consideration of SEK 275 million (Xbrane Biopharma AB)

Public Technologies 20 Mar 2025
2025-03-20 08.00.00 CET Xbrane Biopharma AB - Inside information Xbrane has entered into an agreement to sell XB003 (Cimzia biosimilar candidate) and parts of its organization to Alvotech for a total consideration of SEK 275 million.
  • 1
×